Citations

Clear

352 citation(s) found for "Ward, KA".

Who Are the Next Generation of Genetic Counselors? A Survey of Students
Lega, Melanie, Veach, Patricia McCarthy , Ward, Erin E., LeRoy, Bonnie S.

Mayo Clinic

Journal of Genetic Counseling | September 30, 2005 | Volume: 14 | Issue: 5 | Pages: 395-407

10.1007/s10897-005-3773-8 | PMID 16195946 Get It

AbstractGenetic counseling students were surveyed about their backgrounds, application process to genetic counseling programs, and career motivations and plans. Program directors from 27 accredited programs were asked to distribute 362 surveys to students. Fifty‐two survey items assess demographics; sources of support for pursuing a genetic counseling career (information about genetic counseling, encouragement/discouragement from others); career motivations (reasons for applying and for becoming a genetic counselor); and career certainty. Two hundred and thirty‐five usable surveys were returned (64.9% usable return rate). Most respondents were Caucasian females (mean age = 25.4 years). About 13% identified as ethnic minorities, and about one‐third reported family histories of a genetic condition(s). Most respondents learned about the field in classes, and most were strongly encouraged by family and friends to pursue genetic counseling. Reasons rated as most important for becoming a genetic counselor included helping others and intellectual stimulation. Recruitment, training, and research recommendations are given.
SALVAGE SURGERY FOR RADIORECURRENT PROSTATE CANCER: CONTEMPORARY OUTCOMES
Ward, John F. , Sebo, Thomas J., Blute, Michael L., Zincke, Horst

Mayo Clinic

Journal of Urology | March 2, 2005 | Volume: 173 | Issue: 4 | Pages: 1156-1160

10.1097/01.ju.0000155534.54711.60 | PMID 15758726 Get It

PROSTATE SPECIFIC ANTIGEN DOUBLING TIME SUBSEQUENT TO RADICAL PROSTATECTOMY AS A PROGNOSTICATOR OF OUTCOME FOLLOWING SALVAGE RADIOTHERAPY
Ward, John F. , Zincke, Horst, Bergstralh, Erik J., Slezak, Jeffrey M., Blute, Michael L.

Mayo Clinic

Journal of Urology | November 10, 2004 | Volume: 172 | Issue: 6 Part 1 | Pages: 2244-2248

10.1097/01.ju.0000145262.34748.2b | PMID 15538240 Get It

THE IMPACT OF SURGICAL APPROACH (NERVE BUNDLE PRESERVATION VERSUS WIDE LOCAL EXCISION) ON SURGICAL MARGINS AND BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY
Ward, John F. , Zincke, Horst, Bergstralh, Erik J., Slezak, Jeffrey M., Myers, Robert P., Blute, Michael L.

Mayo Clinic

Journal of Urology | September 15, 2004 | Volume: 172 | Issue: 4 Part 1 | Pages: 1328-1332

10.1097/01.ju.0000138681.64035.dc | PMID 15371834 Get It

Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest
Sengupta, Sagar , Robles, Ana I. , Linke, Steven P. , Sinogeeva, Natasha I., Pedeux, Rémy , Ward, Irene M., Celeste, Arkady, Nussenzweig, André , Halazonetis, Thanos D. , Harris, Curtis C. , Zhang, Ran , Chen, Junjie

Mayo Clinic

The Journal of Cell Biology | September 13, 2004 | Volume: 166 | Issue: 6 | Pages: 801-813

10.1083/jcb.200405128 | PMID 15364958 Get It

Bloom's syndrome is a rare autosomal recessive genetic disorder characterized by chromosomal aberrations, genetic instability, and cancer predisposition, all of which may be the result of abnormal signal transduction during DNA damage recognition. Here, we show that BLM is an intermediate responder to stalled DNA replication forks. BLM colocalized and physically interacted with the DNA damage response proteins 53BP1 and H2AX. Although BLM facilitated physical interaction between p53 and 53BP1, 53BP1 was required for efficient accumulation of both BLM and p53 at the sites of stalled replication. The accumulation of BLM/53BP1 foci and the physical interaction between them was independent of γ-H2AX. The active Chk1 kinase was essential for both the accurate focal colocalization of 53BP1 with BLM and the consequent stabilization of BLM. Once the ATR/Chk1- and 53BP1-mediated signal from replicational stress is received, BLM functions in multiple downstream repair processes, thereby fulfilling its role as a caretaker tumor suppressor.
The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy
Ward, John F. , Blute, Michael L., Slezak, Jeffrey M., Bergstralh, Erik J., Zincke, Horst

Mayo Clinic

Journal of Urology | August 25, 2004 | Volume: 170 | Issue: 5 | Pages: 1872-1876

10.1097/01.ju.0000091876.13656.2e | PMID 14532796 Get It

53BP1 is required for class switch recombination
Ward, Irene M., Reina‐San‐Martin, Bernardo , Olaru, Alexandru, Minn, Kay, Tamada, Koji , Lau, Julie S., Cascalho, Marília , Nussenzweig, André , Livák, Ferenc , Nussenzweig, Michel C. , Nussenzweig, André , Chen, Lieping , Chen, Junjie

Mayo Clinic

The Journal of Cell Biology | May 24, 2004 | Volume: 165 | Issue: 4 | Pages: 459-464

10.1083/jcb.200403021 | PMID 15159415 Get It

53BP1 participates early in the DNA damage response and is involved in cell cycle checkpoint control. Moreover, the phenotype of mice and cells deficient in 53BP1 suggests a defect in DNA repair (Ward et al., 2003b). Therefore, we asked whether or not 53BP1 would be required for the efficient repair of DNA double strand breaks. Our data indicate that homologous recombination by gene conversion does not depend on 53BP1. Moreover, 53BP1-deficient mice support normal V(D)J recombination, indicating that 53BP1 is not required for “classic” nonhomologous end joining. However, class switch recombination is severely impaired in the absence of 53BP1, suggesting that 53BP1 facilitates DNA end joining in a way that is not required or redundant for the efficient closing of RAG-induced strand breaks. These findings are similar to those observed in mice or cells deficient in the tumor suppressors ATM and H2AX, further suggesting that the functions of ATM, H2AX, and 53BP1 are closely linked.
A Polycystin-1 Multiprotein Complex Is Disrupted in Polycystic Kidney Disease Cells
Roitbak, Tamara , Harris, Peter C. , Ness, Scott A. , Wandinger‐Ness, Angela , Ward, Christopher J. , Bacallao, Robert L. , Harris, Peter C

Mayo Clinic

Molecular Biology of the Cell | January 13, 2004 | Volume: 15 | Issue: 3 | Pages: 1334-1346

10.1091/mbc.e03-05-0296 | PMID 14718571 Get It

Autosomal dominant polycystic kidney disease (ADPKD) is typified by the accumulation of fluid-filled cysts and abnormalities in renal epithelial cell function. The disease is principally caused by mutations in the gene encoding polycystin-1, a large basolateral plasma membrane protein expressed in kidney epithelial cells. Our studies reveal that, in normal kidney cells, polycystin-1 forms a complex with the adherens junction protein E-cadherin and its associated catenins, suggesting a role in cell adhesion or polarity. In primary cells from ADPKD patients, the polycystin-1/polycystin-2/E-cadherin/β-catenin complex was disrupted and both polycystin-1 and E-cadherin were depleted from the plasma membrane as a result of the increased phosphorylation of polycystin-1. The loss of E-cadherin was compensated by the transcriptional upregulation of the normally mesenchymal N-cadherin. Increased cell surface N-cadherin in the disease cells in turn stabilized the continued plasma membrane localization of β-catenin in the absence of E-cadherin. The results suggest that enhanced phosphorylation of polycystin-1 in ADPKD cells precipitates changes in its localization and its ability to form protein complexes that are critical for the stabilization of adherens junctions and the maintenance of a fully differentiated polarized renal epithelium.
Atlas of Genitourinary OncologyMovsasB., HudesG. and OlssonC.: Atlas of Genitourinary Oncology. In: . Philadelphia: W. B. Saunders2002: 221 pages.
Zincke, Horst, Ward, John F.

Mayo Clinic

Journal of Urology | November 18, 2003 | Volume: 169 | Issue: 3 | Pages: 1203-1203

10.1097/01.ju.0000047514.48288.b9 Get It

Future Research Directions in Acute Lung Injury: Summary of a National Heart, Lung, and Blood Institute Working Group
Matthay, Michael A. , Esmon, Charles, Bhattacharya, Jahar , Floros, Joanna, Gimbrone, Michael A., Hubmayr, Rolf D., Matalon, Sadis , Munford, Robert S., Parsons, Polly E., Slutsky, Arthur S. , Tracey, Kevin J. , Ward, Peter A. , Gail, Dorothy B., Harabin, Andrea L., Zimmerman, Guy A. , Esmon, Charles T., Coller, Barry S. , Doerschuk, Claire M. , Hoffman, Eric P. , Leppert, Mark

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | March 27, 2003 | Volume: 167 | Issue: 7 | Pages: 1027-1035

10.1164/rccm.200208-966ws | PMID 12663342 Get It

Abstract Acute lung injury (ALI) and its more severe form, the acute respiratory distress syndrome (ARDS), are syndromes of acute respiratory failure that result from acute pulmonary edema and inflammation. The development of ALI/ARDS is associated with several clinical disorders including direct pulmonary injury from pneumonia and aspiration as well as indirect pulmonary injury from trauma, sepsis, and other disorders such as acute pancreatitis and drug overdose. Although mortality from ALI/ARDS has decreased in the last decade, it remains high. Despite two major advances in treatment, low VT ventilation for ALI/ARDS and activated protein C for severe sepsis (the leading cause of ALI/ARDS), additional research is needed to develop specific treatments and improve understanding of the pathogenesis of these syndromes. The NHLBI convened a working group to develop specific recommendations for future ALI/ARDS research. Improved understanding of disease heterogeneity through use of evolving biologic, genomic, and genetic approaches should provide major new insights into pathogenesis of ALI. Cellular and molecular methods combined with animal and clinical studies should lead to further progress in the detection and treatment of this complex disease.